Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
24 09 2019
Historique:
entrez: 25 9 2019
pubmed: 25 9 2019
medline: 15 10 2019
Statut: ppublish

Résumé

Among the general adult population, women (across all ages) have the highest prevalence of asymptomatic bacteriuria, although rates increase with age among both men and women. Asymptomatic bacteriuria is present in an estimated 1% to 6% of premenopausal women and an estimated 2% to 10% of pregnant women and is associated with pyelonephritis, one of the most common nonobstetric reasons for hospitalization in pregnant women. Among pregnant persons, pyelonephritis is associated with perinatal complications including septicemia, respiratory distress, low birth weight, and spontaneous preterm birth. To update its 2008 recommendation, the USPSTF commissioned a review of the evidence on potential benefits and harms of screening for and treatment of asymptomatic bacteriuria in adults, including pregnant persons. This recommendation applies to community-dwelling adults 18 years and older and pregnant persons of any age without signs and symptoms of a urinary tract infection. Based on a review of the evidence, the USPSTF concludes with moderate certainty that screening for and treatment of asymptomatic bacteriuria in pregnant persons has moderate net benefit in reducing perinatal complications. There is adequate evidence that pyelonephritis in pregnancy is associated with negative maternal outcomes and that treatment of screen-detected asymptomatic bacteriuria can reduce the incidence of pyelonephritis in pregnant persons. The USPSTF found adequate evidence of harms associated with treatment of asymptomatic bacteriuria (including adverse effects of antibiotic treatment and changes in the microbiome) to be at least small in magnitude. The USPSTF concludes with moderate certainty that screening for and treatment of asymptomatic bacteriuria in nonpregnant adults has no net benefit. The known harms associated with treatment include adverse effects of antibiotic use and changes to the microbiome. Based on these known harms, the USPSTF determined the overall harms to be at least small in this group. The USPSTF recommends screening pregnant persons for asymptomatic bacteriuria using urine culture. (B recommendation) The USPSTF recommends against screening for asymptomatic bacteriuria in nonpregnant adults. (D recommendation).

Identifiants

pubmed: 31550038
pii: 2751726
doi: 10.1001/jama.2019.13069
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Practice Guideline Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1188-1194

Commentaires et corrections

Type : CommentIn
Type : SummaryForPatientsIn
Type : CommentIn
Type : CommentIn

Auteurs

Douglas K Owens (DK)

Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
Stanford University, Stanford, California.

Karina W Davidson (KW)

Feinstein Institute for Medical Research at Northwell Health, Manhasset, New York.

Alex H Krist (AH)

Fairfax Family Practice Residency, Fairfax, Virginia.
Virginia Commonwealth University, Richmond.

Michael J Barry (MJ)

Harvard Medical School, Boston, Massachusetts.

Michael Cabana (M)

University of California, San Francisco.

Aaron B Caughey (AB)

Oregon Health & Science University, Portland.

Chyke A Doubeni (CA)

Mayo Clinic, Rochester, New York.

John W Epling (JW)

Virginia Tech Carilion School of Medicine, Roanoke.

Martha Kubik (M)

Temple University, Philadelphia, Pennsylvania.

C Seth Landefeld (CS)

University of Alabama at Birmingham.

Carol M Mangione (CM)

University of California, Los Angeles.

Lori Pbert (L)

University of Massachusetts Medical School, Worcester.

Michael Silverstein (M)

Boston University, Boston, Massachusetts.

Melissa A Simon (MA)

Northwestern University, Evanston, Illinois.

Chien-Wen Tseng (CW)

University of Hawaii, Honolulu.
Pacific Health Research and Education Institute, Honolulu, Hawaii.

John B Wong (JB)

Tufts University School of Medicine, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH